ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

XENE Xenon Pharmaceuticals Inc

42.49
1.84 (4.53%)
May 01 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 3.74M8.77M536k132k0000
Operating Income -24.84M-17.37M-30.32M-38.13M-43.33M-47.37M-53.67M-53.06M
Pre Tax Income -25.08M-20.06M-31.2M-37.74M-36.26M-41.44M-47.68M-48.62M
Net Income -23.77M-19.67M-31.16M-37.15M-36.96M-41.73M-47.46M-48.46M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -25.56M-20.73M-31.6M-38.42M-41.32M-47.37M-53.67M-53.06M
EBITDA -24.84M-16.99M-29.94M-38.88M-41.71M-47.01M-53.07M-51.32M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.8M311k06.83M32.17M18.44M9.43M0
Operating Income -24.82M-32.58M-38.02M-42.82M-31.3M-78.99M-129.14M-214.05M
Pre Tax Income -23M-30.7M-34.5M-41.62M-29.09M-78.89M-125.26M-182.69M
Net Income -23M-30.7M-34.5M-41.6M-28.01M-77.09M-124.94M-182.39M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.283-1.706-1.34-1.427-0.778-1.464-1.996-2.42
EBIT -24.82M-32.58M-33.62M-42.82M-32.29M-79.71M-132.08M-214.05M
EBITDA -23.95M-31.93M-37.43M-42.39M-31.3M-78.99M-127.52M-210.51M

Your Recent History

Delayed Upgrade Clock